Yasmin and its sister drug Yaz were introduced in the market over ten years ago. The drugs, made by Bayer, achieved $1.47 billion in sales during 2010 alone. The drug sold well, but proved to have devastating side effects that sometimes proved fatal.
Litigation commenced many years ago and many cases have settled. However, Bayer recently announced it had reached agreements to pay $1 billion in settlements to 4,800 women in the United States who say there were harmed by taking Yasmin or Yaz. These settlements are only applicable to blood clot injuries.
If you have suffered a heart attack, stroke, deep vein thrombosis or pulmonary embolism while taking YAZ® or Yasmin®, contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, to help you assess any claims that you might have against the YAZ® or Yasmin® manufacturers.